72606-049 : Tocilizumab-anoh-anoh 200 mg/10ml Intravenous Injection, Solution, Concentrate
| NDC: | 72606-049 |
| Labeler: | Celltrion USA, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Tocilizumab-anoh |
| Dosage Form: | Intravenous Injection, Solution, Concentrate |
| Application #: | BLA761420 |
| Rev. Date: |
NDC Package Codes:
- 72606-049-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (72606‑049‑01) / 10 ML IN 1 VIAL, SINGLE‑DOSE
- 72606-049-02: 4 VIAL, SINGLE‑DOSE IN 1 CARTON (72606‑049‑02) / 10 ML IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Tocilizumab
Dosage Strength:
- 200 mg/10mL
Pharmaceutical Classes:
- Interleukin 6 Receptor Antagonists [MoA]
- Interleukin-6 Receptor Antagonist [EPC]
Related Products:
Based on records with the same trade name.- 72606-048 Tocilizumab-anoh-anoh 80 mg/4ml Intravenous Injection, Solution, Concentrate by Celltrion USA, Inc.
- 72606-050 Tocilizumab-anoh-anoh 400 mg/20ml Intravenous Injection, Solution, Concentrate by Celltrion USA, Inc.
- 72606-051 Tocilizumab-anoh-anoh 162 mg/.9ml Intravenous Injection, Solution, Concentrate by Celltrion USA, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 72606-048Next: 72606-050 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.